These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8547082)

  • 1. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.
    Enright H; Jacob HS; Vercellotti G; Howe R; Belzer M; Miller W
    Br J Haematol; 1995 Oct; 91(2):403-8. PubMed ID: 8547082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Saif MW; Hopkins JL; Gore SD
    Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune phenomena in patients with myelodysplastic syndromes.
    Enright H; Miller W
    Leuk Lymphoma; 1997 Feb; 24(5-6):483-9. PubMed ID: 9086438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic and autoimmune manifestations in myelodysplastic syndromes].
    Fain O; Braun T; Stirnemann J; Fenaux P
    Rev Med Interne; 2011 Sep; 32(9):552-9. PubMed ID: 20850913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune manifestations associated with myelodysplastic syndromes.
    Grignano E; Jachiet V; Fenaux P; Ades L; Fain O; Mekinian A
    Ann Hematol; 2018 Nov; 97(11):2015-2023. PubMed ID: 30091023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndrome associated with multiple autoimmune disorders.
    Farmakis D; Polymeropoulos E; Polonifi A; Deftereos S; Giakoumi X; Floudas H; Grapsa A; Aessopos A
    Clin Rheumatol; 2005 Aug; 24(4):428-30. PubMed ID: 15827686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)].
    Bouali F; Berrah A; Si Ahmed-Bouali D; Harrieche F; Benhalima M; Hamladji RM; Arrada M
    Rev Med Interne; 2005 Oct; 26(10):777-83. PubMed ID: 16203055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?
    Braun T; Fenaux P
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):327-36. PubMed ID: 24507810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between myelodysplastic syndromes and autoimmune disorders.
    Zhao S; Mao H; Wang H; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):311-3. PubMed ID: 12411063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of erythema nodosum and serositis associated with myelodysplastic syndrome.
    Choi JH; Ahn MJ; Park YW; Oh HS; Lee YY; Kim IS
    Korean J Intern Med; 2005 Jun; 20(2):177-9. PubMed ID: 16134776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of relapsing polychondritis after successful treatment of myelodysplastic syndrome with azacitidine: a case and review of the literature.
    Erden A; Bilgin E; Kılıç L; Sarı A; Armağan B; Büyükaşık Y; Kalyoncu U
    Drug Metab Pers Ther; 2018 Jun; 33(2):105-108. PubMed ID: 29715182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.
    Giannouli S; Voulgarelis M; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    Rheumatology (Oxford); 2004 May; 43(5):626-32. PubMed ID: 14983106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Auto-immune diseases and cancers. Second part: auto-immune diseases complicating cancers and their treatment].
    Pasquet F; Pavic M; Ninet J; Hot A
    Rev Med Interne; 2014 Oct; 35(10):656-63. PubMed ID: 25106665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myelodysplasias and systemic diseases. A non-fortuitous association].
    Berthier S; Magy N; Gil H; Schneider MB; Vuitton DA; Dupond JL
    Rev Med Interne; 2001 May; 22(5):428-32. PubMed ID: 11402513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases.
    Giannouli S; Voulgarelis M
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1679-88. PubMed ID: 25308147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune diseases and myelodysplastic syndromes.
    Komrokji RS; Kulasekararaj A; Al Ali NH; Kordasti S; Bart-Smith E; Craig BM; Padron E; Zhang L; Lancet JE; Pinilla-Ibarz J; List AF; Mufti GJ; Epling-Burnette PK
    Am J Hematol; 2016 May; 91(5):E280-3. PubMed ID: 26875020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
    Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study.
    Wesner N; Drevon L; Guedon A; Fraison JB; Trad S; Kahn JE; Aouba A; Gillard J; Ponsoye M; Hanslik T; Gourguechon C; Liozon E; Laribi K; Rossignol J; Hermine O; Adès L; Carrat F; Fenaux P; Mekinian A; Fain O;
    Eur J Haematol; 2019 Jan; 102(1):63-69. PubMed ID: 30218579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated PACNS-like presentation of a systemic vasculitis complicating a myelodysplastic syndrome.
    Incalzi RA; Arena V; Capelli A; Gambassi G
    J Intern Med; 2004 Jun; 255(6):674-9. PubMed ID: 15147531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome.
    Williamson BT; Foltz L; Leitch HA
    Hematol Rep; 2016 May; 8(2):6480. PubMed ID: 27499837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.